Alvogen is a privately owned US-based pharmaceutical company that focuses on developing, licensing, manufacturing, and marketing pharmaceutical products. With a targeted portfolio of complex high-value products, including inhalation injectables and strategic 505(b)(2) products, Alvogen is dedicated to making high-quality medicines accessible to improve people's lives.
Founded in the midst of a financial crisis in 2009, Alvogen's mission is to produce medicines that help individuals lead longer, healthier, and more active lives. The company values partnerships and collaboration, emphasizing the importance of strategic alliances to drive its future growth and global impact.
Generated from the website